Health Holland Research Grant Awarded

Aug 8, 2019

Funding for a 2-year research collaboration entitled “Improved personalized vaccines against cancer: quality of T cell immunity matters” has been awarded by Health Holland.

In this project Immunetune will collaborate with Leiden University Medical Center to further optimize cancer vaccines by inclusion of specific CD4 helper epitopes.

Neoantigen Summit Europe, April 7-9 in Amsterdam

Neoantigen Summit Europe, April 7-9 in Amsterdam

CEO Gerben Zondag will present Immunetune's unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam.

read more